Granahan Investment Management’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
CC
ACM
PGM
SAM
BGIM
FWC
Granahan Investment Management's STIM Position: Q4 2021 in Review
Granahan Investment Management sold out of Neuronetics (STIM) in Q4 2021, closing a stake of 880,203 shares — an estimated $5.77M sold.
Granahan Investment Management first reported a position in STIM in Q2 2018 and held it in 10 quarters. The position peaked at $11.7M in Q2 2021. 80 funds tracked by Wall St. Rank hold STIM as of Q4 2021.
- Granahan Investment Management reported no remaining Neuronetics position as of Q4 2021 after selling out during the quarter.
- Granahan Investment Management sold 880,203 Neuronetics shares in Q4 2021, an estimated $5.77M.
- Granahan Investment Management first reported a position in Neuronetics in Q2 2018 and held it in 10 quarters.
- Granahan Investment Management's Neuronetics position peaked at $11.7M in Q2 2021.
- 80 funds tracked by Wall St. Rank held Neuronetics as of Q4 2021.
Based on Granahan Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.